OA pre-treatment attenuated PA-induced mitochondrial dysfunction and insulin resistance by inhibiting the phosphorylation of mitogen-activated protein kinase and nuclear translocation of NF-κB p65 induced by PA (Kwon, Lee & Querfurth, 2014). Here, WNK2 is linked to Insulin resistance.